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Abstract. The slow force response (SFR) of a cardiac muscle to a sudden stretch is thought to be 
important in the regulatory adaptation of myocardial contraction. Autocrine-paracrine regulation 
pathways which involve angiotensin  II are participating in this mechanism. On the other hand, 
renin-angiotensin-aldosterone system (RAS) is altered in hypertrophic or failing myocardium. We 
compared the effects of sudden stretch to SFR as well as to twitch and Ca2+ transient characteristics 
in rat myocardium with monocrotaline-induced heart failure with those in normal rat myocardium 
without and with inhibition of angiotensin II type-1 (AT1) receptors. Our findings indicate that the 
myocardium of rats with monocrotaline-induced right ventricular failure is deficient with activation 
of local RAS and therefore expresses blunted SFR, very similar to the depression of SFR observed in 
normal myocardium under inhibition of AT1 receptors. The “failing” myocardium does not further 
respond to the “putative” inhibition of AT1 receptors by losartan. In conclusion, SFR is related to 
autocrine-paracrine regulation of myocardial contraction in normal rat myocardium and that the 
involvement of RAS into stretch-induced modulation of contractility may be significantly altered 
in failing heart.
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Introduction
The sudden stretch of heart muscle causes rapid increase in 
its contractility (the Frank-Starling mechanism) followed 
by the slow force response (SFR). The SFR in mammalian 
myocardium is attributed to a long-term adaptation of the 
heart to environmental conditions and confirmed in many 
mammals including human, and on different levels of myo-
cardial tissue – from single cell to whole organ (Hongo et 
al. 1996; Kentish and Wrzosek 1998; Todaka et al. 1998; von 
Lewinski et al. 2003; Calaghan and White 2004; von Lewinski 
et al. 2004; Kockskämper et al. 2008).
The exact mechanisms of SFR remain unclear but they 
require slow change in cytosolic Ca2+ (Cingolani et al. 2013; 
Shen et al. 2013). It has been proposed initially that Ca2+ 
entry into a cell is elevated in stretched myocardium due to 
the stretch-activated channels (Zeng et al. 2000; Calaghan 
and White 2004). Transient receptor potential cation chan-
nels (TRPCs) are also stretch-sensitive and therefore may 
facilitate Ca2+ entry in the response to mechanical stress 
(Barritt and Rychkov 2005; Yamaguchi et al. 2018), as well 
as stretch-induced changes in phosphorylation of regula-
tory proteins of the contractile filaments (Monasky et al. 
2010). Another pathway is the stretch-initiated increase in 
metabolic demand and stimulation of Na+ entry via both 
sodium-hydrogen exchanger (NHE) and Na+/HCO3− 
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transporters with subsequent activation of sodium-calcium 
exchanger (NCX) in reverse mode and Ca2+ accumulation 
in a cell (Bluhm et al. 1998; Shen et al. 2013). More com-
plex mechanism of autocrine-paracrine regulation in the 
response to stretch has been recently proposed: release of 
angiotensin II (Ang II) → activation of Ang II type-1 recep-
tors (AT1 receptors) → activation of NHE-1 → activation of 
NCX in reverse mode and Ca2+ accumulation in the cell 
(Pérez et al. 2003, 2011; Vargas et al. 2013). Accordingly 
to recent studies, mineralocorticoids are also involved into 
activation of NHE-1 via control of redox-sensitive kinases; 
inhibition of mineralocorticoid receptors therefore affects 
the above mentioned autocrine-paracrine mechanism of 
slow force response (Ennis et al. 2013; Díaz et al. 2014). 
The slow adaptation of myocardial contractility is altered 
under hypertrophy or heart failure. Moreover, the progres-
sion of cardiac hypertrophy involves the same mechanisms 
as of SFR, e.g. the release of endogenous Ang II and/or en-
dothelin and further activation of AT1 receptors in stretched 
myocardium (Ito et al. 1993; Sadoshima et al. 1993; Malhotra 
et al. 1999; Pérez et al. 2003; Cingolani et al. 2011). Moreover, 
stretch may trigger the activation of AT1 receptors without 
release of Ang II (Yasuda et al. 2008). Other mechanisms like 
TRPCs may also contribute to the pathological remodeling in 
sustained hypertension, affecting cell hypertrophic signaling 
triggered by Ang II or ET-1 (Seo et al. 2014). Since SFR is 
originated at least in part from some of these mechanisms, 
slow changes in contractility in pathology may substantially 
differ from their typical shape/extent observed in normal 
myocardium.
Therefore, we were motivated to evaluate the effect of de-
pletion of local renin-angiotensin system (RAS) by inhibition 
of AT1 receptors on the background of systemic upregulation 
of RAS in monocrotaline-treated rats with right ventricular 
failure. We compared stretch-induced slow changes in twitch 
and Ca2+ transient characteristics in right ventricular myo-
cardium of monocrotaline-treated rats with those obtained 
in normal myocardium without and with inhibition of AT1 
receptors in order to elucidate a role of RAS in slow adapta-
tion of contractility in diseased myocardium. 
Materials and Methods
Ethical approval
The authors assure that the animal experiments were carried 
out in accordance with EU regulations (86/609/EEC) and 
the use of the animals was reviewed and approved by the 
local Institutional Ethics Committee. Rats were obtained 
from the Institutional Animal House and maintained under 
a 12 h  light-dark cycle with free access to standard chow 
and water.
Experimental model of monocrotaline-induced heart failure 
Monocrotaline was used to develop pulmonary hypertension 
followed by severe right ventricular hypertrophy. Briefly, 
4-week-old Wistar rats of both sexes (weighing 80–100 g) 
were randomly divided into control (normal myocardium) 
and monocrotaline-treated (hypertrophic myocardium) 
groups. Rats in monocrotaline-treated group were given 
a single subcutaneous injection of saline solution containing 
monocrotaline (2 ml/kg; final concentration 50 mg/kg body 
weight), whereas rats in the control group were injected with 
an equivalent volume of saline solution. Monocrotaline-
treated rats (n = 37 in total) were killed as soon as loss of 
body weight and dyspnea at rest became prominent (23.3 ± 
0.5 days after treatment). Control rats (n = 22 in total) were 
killed at the same age. The validity of the experimental model 
of pulmonary hypertension and severe hypertrophy/heart 
failure in young rats has been tested and confirmed in our 
recent study (Lookin et al. 2015b). The above described treat-
ment induced substantial increase in right ventricular mass 
by ~50% with significant loss of left ventricular mass by ~30% 
indicating a marginal state between severe hypertrophy and 
heart failure. For a reason of uniformity, elsewhere in the text 
we use term “failing” to refer this state of the myocardium. 
Muscle isolation
Animals were anaesthetized with 15 mg/kg zolazepam (Zo-
letil100®; Virbac, Carros, France) and killed by rapid cervical 
dislocation. The heart was quickly excised and placed in 
modified Krebs–Henseleit (K-H) solution (in mM: NaCl 
118.5; KCl 4.2; MgSO4 1.2; CaCl2 2.5; glucose 11.1) equili-
brated in 95% O2 + 5% CO2 with NaHCO3 and KH2PO4 to 
maintain pH at 7.35. Papillary muscles were dissected from 
the right ventricle, clipped to force transducer and length 
servomotor (Muscle Research System; Scientific Instruments 
GmbH, Heidelberg, Germany) in experimental bath and 
continuously bathed in K-H solution. The mean diameter 
of the used muscles was 258 ± 22 μm for normal heart (n = 
22; 6 males/16 females) vs. 316 ± 23 μm for failing heart 
(n = 37, 16 males/21 females). Force and length (as well as 
fura-2 intensity in several measurements, see below) were 
sampled at 10 kHz using an analog-to-digital (A/D) and 
D/A data converter (PCI-1716S; AdLink Technology, New 
Taipei City, Taiwan) and custom-made software running 
in a real-time environment (HyperKernel; Nematron, Ann 
Arbor, MI, USA) integrated with Windows XP (Microsoft; 
Redmond, WA, USA). Data were processed and analysed 
off-line using custom-made software. All experiments were 
carried out at 25°C and pacing rate of 0.33 Hz. All chemicals 
were purchased from Sigma-Aldrich (St. Louis, MO, USA) 
except potassium losartan (Merck Sharp & Dohme Corp, 
Haarlem, The Netherlands).
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Experimental protocols
A muscle was released to the length where no passive force 
was developed; this length was assumed as slack length. The 
muscle was then stretched gradually for approximately 2–3% 
of the slack length and allowed to equilibrate at the new length 
prior to further measurements. When no further increase 
in the amplitude of active tension was observed, the final 
length was assumed as LMAX. A protocol of sudden stretch 
of isometrically contracting muscle from 85% to 95% LMAX 
was applied to measure slow changes in contractile activity 
of a muscle, i.e. slow force response (SFR), slow twitch-to-
twitch changes in certain characteristics. Rapid stretch event 
lasted ~100 ms and muscle contractions at the new length 
were recorded continuously during 5 or 10 minutes. If neces-
sary, the protocol was repeated 2 or 3 times more, every time 
a muscle was released and kept at 85% LMAX during 5–10 min 
prior to the next stretch. Averaged slow response in a muscle 
was obtained from individual responses. To compare the ex-
pression of slow changes in contractility between individual 
muscles, we normalized the value of given characteristics in 
each twitch to the value obtained in first twitch after stretch 
(T2 value, see Fig. 1A). 
We also examined the effect of inhibition of AT1 recep-
tor on the expression of slow changes in contractility in the 
myocardium of control and monocrotaline-treated rats. 
The slow responses were measured in standard K-H solu-
tion, then a selective inhibitor of AT1 receptors (100 μmol/l 
losartan) was added to the solution and the measurements 
were repeated 30 min later. For some of the measurements 
in normal myocardium, free cytosolic Ca2+ was monitored 
simultaneously with isometric twitch by fluorescent indica-
tor fura-2 added into the solution in its cell-permeating 
form (5 μM fura-2/AM + 5% w/v Pluronic F-127). Fura-2 
signals were obtained as a ratio of light intensities collected 
at 510  nm wavelength by excitation at either 340 nm or 
380 nm (F = F340/F380) and presented here as F/F0, where 
F0 is a ratio measured in quiescent muscle at slack length 
(i.e. when no stretch is applied).
Statistical analysis
Results are presented as means ± SEM. Differences in twitch/
Ca2+ transient characteristics between normal and “failing” 
myocardium obtained in the time-matched manner dur-
ing stretch protocol (i.e. before stretch, immediately after 
stretch, at the end of response) were evaluated by one-way 
ANOVA followed by the Newman–Keuls test. Differences in 
the time-matched data obtained in the absence and presence 
of losartan in the saline were tested by two-way ANOVA. 
Effects were considered significant at p < 0.05.
Results
Slow response of contractility in normal and “failing” rat 
myocardium
Table 1 summarizes the mean values of characteristics of 
single isometric twitch measured in right ventricular myo-
cardium of control and monocrotaline-treated rats before, 
immediately after, and at the end of slow response to rapid 
stretch. Note that “failing” rat myocardium was significantly 
weaker compared to normal myocardium under steady-
state conditions (e.g. before stretch or at the end of slow 
response to stretch). Immediately after the stretch, mean 
values of peak active tension were not significantly different 
between normal vs. “failing” myocardium (45.2 ± 4.7 vs. 34.4 
Figure 1. Slow force response to rapid stretch. A. Typical scheme of slow changes in twitch amplitude developed after rapid stretch of 
a muscle. T1, twitch amplitude before stretch; T2, twitch amplitude immediately after stretch; T3, twitch amplitude at the end of slow 
changes. The visual representation of this scheme is based on the figure from (Bluhm et al. 1998). B. Slow changes in peak active tension 
measured in normal and “failing” (HF) rat myocardium after rapid stretch of a muscle from 85% to 95% LMAX, presented in a % of T2 
value; dashed line shows T2 level. Data in panel B are presented as mean ± S.E.M, the range for significant difference in time-matched 
change between normal and failing myocardium is marked by horizontal line with asterisk (p < 0.05).
A B
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± 2.5  mN/mm2, respectively). The rising phase of twitch 
(tension development) was always substantially slower and 
prolonged in the “failing” myocardium, regardless the stage 
of slow response. However, the maximal rate of tension de-
cline during relaxation phase, if expressed in absolute values, 
was not significantly different between normal and “failing” 
myocardium. As similar, time to decline from peak tension 
to half-amplitude (T50) was not different between normal 
and “failing” myocardium at either stage of slow response. 
We further compared relative changes in slow response 
of twitch amplitude between normal and “failing” rat myo-
cardium. For the given slow response, peak active tension 
was measured immediately after stretch (T2) and at the end 
of response (T3, Fig. 1A). The absolute changes in the active 
tension during slow response were therefore evaluated as 
a % of T2 value. While rapid stretch induced similar rela-
tive increase in peak active tension in normal and “failing” 
myocardium during several twitches immediately after 
stretch, further changes were significantly different both in 
the extent and shape (Fig. 1B). The myocardium of untreated 
rats developed positive response, in contrast to “failing” 
myocardium of MCT-treated rats where slow depression of 
peak active tension back to T2 value was observed. At the end 
of response, the muscles from control and monocrotaline-
treated rats developed 116.3 ± 1.3% and 98.7 ± 1.0% of T2 
value, respectively (difference is significant, p < 0.05). 
Effect of inhibition of angiotensin II type-1 (AT1) receptors 
on slow response of contractility in normal and “failing” rat 
myocardium
It has been conceived that slow force response in normal 
myocardium is regulated by complex pathway of molecular 
event involving Ang II/endothelin secretion (Alvarez et al. 
1999; Cingolani et al. 2013). To test whether the pathway 
is in operation under our experimental conditions, we 
compared twitch characteristics during slow responses to 
stretch in normal rat myocardium before and after inhibi-
tion of AT1 receptors by perfusion of muscles with modified 
Krebs-Henseleit solution + 100 μmol/l losartan for 30 min 
(n = 12). This set of measurements utilized separate pool of 
muscles not involved into calculations presented in Table 1.
For some of the muscles, Ca2+ transients were simul-
taneously measured in 30-s intervals every 2 min during 
10-min response to sudden stretch (n = 7). In this set of 
measurements we checked whether the slow changes in peak 
tension are accompanied by slow changes in the kinetics of 
free cytosolic calcium. Some previous reports (Hongo et 
al. 1996; Kentish and Wrzosek 1998; Calaghan and White 
2004; Shen et al. 2013; Yamaguchi et al. 2018) showed that 
the slow stretch-related increase in contractility develops in 
parallel to the slow amplification of peak systolic calcium. 
We hypothesize that the characteristics of Ca2+ transient 
decline, rather than its amplitude, may be more effective in 
evaluation of slow changes in Ca2+ utilization by contractile 
machinery and therefore slow development of extra force. As 
reported previously in (Kentish and Wrzosek 1998; Lookin et 
al. 2015a, 2015b), the shape of Ca2+ transient decay in a rat 
ventricular cardiomyocytes strongly depends on the extent 
of muscle stretch. The larger stretch the more prominent 
is the phase of short-term deceleration of Ca2+ transient 
decay, i.e. “bump”. At any stretch applied, one can evaluate 
the extent of the “bump” by measuring its amplitude and/
or integral intensity (for methodological details see (Lookin 
et al. 2015a, 2015b)). Moreover, it is conceiving that under 
steady-state contraction the prominence of the “bump” (e.g. 
evaluated as integral intensity) is strongly and positively 
correlated to the amplitude of contraction. Therefore, we 
evaluated how closely are related the slow force changes and 
the slow changes in the integral intensity of the “bump”. To 
complete this, the Ca2+ transients were averaged in 30 s in-
tervals measured immediately after stretch and then every 
Table 1. The characteristics of single isometric twitch measured before, immediately after, and at the end of slow response to sudden 
stretch in right ventricular papillary muscles isolated from control (normal myocardium) and monocrotaline-treated (heart failure) rats
Normal myocardium (n = 10) Heart failure (n = 16)
before after end before after end
Peak active tension 16.4 ± 2.3* 45.2 ± 4.7 52.2 ± 5.1* 10.6 ± 1.2 34.4 ± 2.5 34.0 ± 2.6
dT/dt(dev) 198 ± 26* 449 ± 43* 559 ± 52* 98 ± 11 294 ± 22 304 ± 24
dT/dt(dec) 91 ± 11 180 ± 18 202 ± 20 61 ± 7 164 ± 13 157 ± 13
TTP 158 ± 3* 187 ± 4* 171 ± 3* 206 ± 5 220 ± 6 209 ± 5
T50 119 ± 5 177 ± 7 176 ± 7 127 ± 4 167 ± 6 167 ± 5
Peak active tension, in mN/mm2; dT/dt(dev), maximal rate of rising phase of isometric twitch (development) – absolute values in 
mN/mm2 per second; dT/dt(dec), maximal rate of isometric twitch decline – absolute values mN/mm2 per second; TTP, time from 
the onset of stimulus to peak active tension (ms); T50, time interval of decline from peak active tension to half-amplitude of peak 
tension (ms). The slow responses were monitored during 5 minutes. * significant difference between normal and “failing” myocardium 
at the same stage of slow response (p < 0.05).
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2 min during the response. Next, the “bump” was extracted 
from every averaged Ca2+ transient. At any time interval (0, 
2, 4, 6, 8 and 10 min after stretch), the integral intensity of 
the bump was evaluated relatively to the integral intensity 
of monotonously declined Ca2+ transient (area under the 
transient trace minus “bumped” part) and then expressed in 
a % of this value obtained immediately after stretch. 
The examples of Ca2+ transients measured in right ven-
tricular myocardium of normal and monocrotaline-treated 
rats during the slow force response in different conditions, 
e.g. in losartan-free or losartan-containing solution, are 
shown in Fig. 2. These experimental records demonstrate 
that Ca2+ transient decline may reveal slow modification 
in its shape during the slow response to rapid stretch. The 
slow changes were more expressed in normal vs. failing 
myocardium (compare Fig. 2A and 2B) which correlates with 
more pronounced slow changes in contractility. Therefore 
we performed quantitative evaluation of this correlation 
between peak tension and cytosolic calcium.
The perfusion of myocardial preparations from normal 
hearts in losartan-containing medium was not followed by 
significant change in absolute values of twitch amplitude 
or duration, compared to the losartan-free solution, either 
in pre-stretch condition (at 85% LMAX), immediately after 
stretch to 95% LMAX, or at the end of slow response; e.g, mean 
absolute values of peak active tension in case of absence/pres-
ence of losartan in the saline were equal to, respectively, 15.6 
± 3.3/18.2 ± 3.7 mN/mm2 before stretch, 38.3 ± 7.7/42.6 ± 
8.0 mN/mm2 immediately after stretch, and 42.1 ± 8.2/40.8 
± 7.9 mN/mm2 at the end of slow response (differences are 
non-significant between absence/presence of losartan at 
any stage). Ca2+ transient end-diastolic level displayed no 
change either with stretch or application of losartan, while 
end-systolic level was slightly elevated in losartan-containing 
saline regardless the extent of stretch, e.g. 1.44 ± 0.09 vs. 1.52 
± 0.15 F/F0 at 85% LMAX, 1.45 ± 0.11 vs. 1.50 ± 0.15 F/F0 
under steady-state condition at 95% LMAX in losartan-free 
and losartan-containing saline, respectively (no significant 
difference). As similar, Ca2+ transient time-to-peak was 
somewhat higher in the losartan-perfused muscles at any 
extent of stretch, e.g. 68.9 ± 9.8 vs. 85.6 ± 15.6 ms at 85% 
LMAX, 56.2 ± 6.3 vs. 63.5 ± 8.9 ms under steady-state condi-
tion at 95% LMAX in losartan-free and losartan-containing 
saline, respectively (no significant difference). 
While application of losartan in normal myocardium 
induced virtually no changes in the steady-state isometric 
twitch and Ca2+ transient, it resulted in significant depres-
sion of stretch-induced slow increase in peak active tension 
in the normal rat myocardium. Thus, at the end of 10-min 
interval after sudden stretch the peak active tension was 
112.7 ± 2.0% of T2 value (i.e. immediately after stretch) in 
losartan-free solution but only 96.8 ± 2.3% of T2 value in 
Figure 2. The stretch-induced slow changes in the shape of Ca2+ transient in right ventricular myocardium of normal and monocrotaline-
treated rats after rapid stretch of a muscle from 85% to 95% LMAX under perfusion in saline without and with 100 μM losartan. A. Ca2+ 
transients obtained in a trabecula of normal rat immediately after stretch (0 min) and after 4 and 10 minutes after the stretch in losartan-
free saline. Dotted line shows monotonic component of Ca2+ transient decline; the difference between the original and monotonic traces 
is the “bump” component. The last plot in panel A shows superimposed Ca2+ transients obtained in the same muscle for the same time 
points after rapid stretch under perfusion in 100 μM losartan in saline. B. Ca2+ transients obtained in a trabecula of monocrotaline-treated 
rat. The plot composition is the same as in panel A. Ca2+ transients are normalized to their respective peak. Note prominent “bump” in 
the muscle from normal rat whereas much less “bump” is observed in the muscle from monocrotaline-treated rat.
A
B
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the presence of 100 μmol/l losartan in solution (significant 
difference at p  < 0.05, Fig. 3A). Note that this losartan-
induced depression of slow increase in peak tension is 
quantitatively similar to that observed between normal and 
“failing” myocardium under perfusion with losartan-free 
saline (compare Fig. 3A and Fig. 1B). 
Surprisingly, Ca2+ transient peak systolic and end-
diastolic levels showed no changes during the slow response 
both in losartan-free and losartan-containing solution (the 
respective values at the end of response are given as % of 
T2 value; end-diastolic level: 100.0 ± 0.1 and 100.0 ± 0.2%; 
peak systolic level: 99.5 ± 1.5 and 99.2 ± 0.9%). In contrast, 
the relative integral intensity of the “bump” progressively 
increased during 10-min slow force response in losartan-
free solution (up to 139.1 ± 7.7% of T2 value) but the 
prominent decrease was observed in losartan-containing 
medium (to 78.7 ± 7.9%, Fig. 3B). These changes in the 
integral intensity of the Ca2+ transient “bump” were in 
close semblance to the changes in the peak active tension 
developed during the slow response to stretch (compare 
Fig. 3B and Fig. 3A).
The impairment of angiotensin II involving pathway in 
“failing” myocardium may explain drastic depletion of slow 
force response as observed in muscles from monocrotaline-
treated rats (see Fig. 1B). If so, the application of losartan 
would make no effect on the slow force changes. Moreover, 
the lack of slow changes in force should imply no or minor 
slow changes in the integral intensity of “bump”. To con-
firm this, we tested effects of inhibition of AT1 receptors 
on slow response in the muscles isolated from the hearts of 
monocrotaline-treated rats with right ventricular failure. 
Preparations different from those shown in Fig. 1B were 
used in this separate set of measurements (n = 21); the twitch 
characteristics of both sets of the muscles were not different. 
For some of the muscles, Ca2+ transients were simultaneously 
measured in 30-s intervals every 2 min during 10-minute 
response to sudden stretch to retrieve slow changes in the 
“bump” characteristics (n = 6).
Application of losartan in the “failing” myocardium had 
no effect on absolute characteristics of isometric twitch; e.g, 
mean value of peak active tension in absence vs. presence 
of losartan in the saline was amounted to, respectively, 
14.4 ± 3.2 vs. 16.9 ± 3.7 mN/mm2 before stretch, 37.0 ± 
2.9 vs. 37.1 ± 3.0 mN/mm2 immediately after stretch, and 
36.1 ± 2.9 vs. 35.5 ± 2.8 mN/mm2 at the end of response. 
If evaluated in terms of T2 value, the peak active tension 
at the end of response amounted to 97.5 ± 1.5% and 96.0 ± 
1.9% of T2 value in losartan-free and losartan-containing 
saline, respectively (Fig. 4A). As similar, the slow changes 
in the relative integral intensity of Ca2+ transient “bump” 
were found to be insensitive to losartan and amounted to 
87.1 ± 4.3% and 88.2 ± 2.8% of T2 value in losartan-free 
and losartan-containing saline, respectively (Fig. 4B). Note 
that paralleled changes in contractility and “bump” integral 
intensity were still observed in the “failing” myocardium. 
This strongly supports the idea that characterization of 
stretch-induced effects on Ca2+ transient decline may pro-
vide useful information about calcium-induced modulation 
of contractility.
Discussion
The slow force response (SFR) of a heart muscle to rapid 
stretch is pronounced in the right ventricular myocardium 
of healthy rats, in contrast to the myocardium of monocro-
taline-treated rats with developed right ventricular failure 
(“failing” myocardium). In the present study we found that 
the extent of SFR depression in the “failing” rat myocardium 
was similar to that observed in normal rat myocardium with 
inhibited AT1 receptors by losartan. Our results are in good 
accordance with the conception that slow force response 
A B
Figure 3. The effect of losartan on the slow changes in peak active tension and relative integral intensity of Ca2+ transient “bump” in 
normal rat myocardium after rapid stretch of a muscle from 85% to 95% LMAX under perfusion in saline without and with 100 μM lo-
sartan (n = 12 for mechanics, n = 7 for “bump” measurements). A. Peak active tension. B. Relative integral intensity of “bump”. Changes 
are presented in a % of value measured immediately after stretch (T2 value), dashed line shows T2 level. Data are presented as mean ± 
S.E.M, the range for significant difference in time-matched change between absence and presence of losartan in the saline is marked by 
horizontal line with asterisk (p < 0.05).
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is regulated via activation of AT1 receptors by endogenous 
Ang II in normal cardiomyocytes and support that a com-
mon mechanism is participating in the deficiency of SFR 
in “failing” myocardium and in normal myocardium with 
altered function of key player(s) in autocrine-paracrine 
mechanism of stretch-related force regulation (Cingolani et 
al. 2011; Pérez et al. 2011; Cingolani et al. 2013). Our data 
about the depression of SFR in the myocardium of rats with 
heart failure are in agreement with recent report (von Lewin-
ski et al. 2009) where SFR in failing human myocardium 
was little expressed. Therefore, activation of AT1 receptors 
is thought to be important mechanism of slow adaptation of 
ventricular contractility in mammalian hearts. Interestingly, 
the SFR is not observed in cardiac muscles with already 
elevated levels of Ang II prior to stretch (Neves et al. 2013). 
Therefore, the lack of the effect of losartan on slow force 
changes in the myocardium of monocrotaline-treated rats 
may reflect either the silencing of angiotensin secretion or 
augmented activation of AT1 receptors under pathological 
remodeling of cardiac cell in this model of right ventricular 
failure. A direct effect of losartan on metabolic processes like 
glucose oxidation, as recently reported in fat cells (Camin-
hotto et al. 2016), is hardly believed in the muscles because 
of the great suppression of SFR in normal myocardium 
under perfusion by losartan and the absence of this effect 
in “failing” muscles.
Authors note that our ambient conditions were out of 
physiological. Our primary goal was to study the phenom-
enon of slow force response and to provide direct data on 
its preservation/disappearance in failing myocardium. Fast 
stimulation (but still limited to 2–2.5 Hz in the most of re-
ported biophysical studies) and physiological temperature 
extremely accelerates the processes involved into genera-
tion of slow changes in force after rapid length change. For 
instance, subphysiological conditions strongly affect Ca2+ 
kinetics in cardiomyocytes (both in single twitch and in 
cycle-to-cycle changes). It becomes hard to monitor such 
changes if they are fast and quite minor. Moreover, persistent 
physiological conditions affect the stability of Ca2+ indicators 
so prolonged fluorescent measurements in these conditions 
(>30–60 minutes) are not achievable. 
Also, we used much higher concentration of losartan in 
the present study if compared to other reports. The reason 
is that we found less consistent effects at lower concentra-
tions (1 and 10 μM) in terms of incomplete depression of 
slow force response. The largest concentration we used in 
the preliminary set of measurements (100 μM) was effective 
and completely abolished slow force response. The difference 
between our conditions and the others may originate from 
different suppliers/manufacturers (we used Merck Sharp & 
Dohme while other groups used Sigma) as well as different 
animal species (Thomas et al. 1996; Cingolani et al. 1998). 
Also, losartan acts in dose-dependent manner and the effec-
tive concentration of losartan depends on the actual level of 
Ang II (Shao et al. 1998).
In contrast to some previous reports (Hongo et al. 1996; 
Kentish and Wrzosek 1998; Calaghan and White 2004; 
Yamaguchi et al. 2018) we did not observe paralleled changes 
in peak active tension and end-diastolic or end-systolic 
level of Ca2+ transient in normal rat myocardium bathed 
in losartan-free or losartan-containing solution. However, 
we found that stretch-induced slow changes in peak active 
tension are highly conformed to the changes in Ca2+ tran-
sient decay morphology, specifically to the phase of brief 
deceleration of this decay (“bump”). In particular, the strong 
conformity between slow changes in peak contraction and 
“bump” integral intensity was observed both in normal and 
“failing” myocardium either in losartan-free or losartan-
containing conditions. We conclude that slow changes in 
Ca2+ transient decline, rather than in its amplitude or peak 
level, may relate more closely to the stretch-induced devel-
opment of contraction.
Figure 4. The effect of losartan on the slow changes in peak active tension and relative integral intensity of Ca2+ transient “bump” in the 
myocardium of monocrotaline-treated rats with right ventricular failure after rapid stretch of a muscle from 85% to 95% LMAX under 
perfusion in saline without and with 100 μM losartan (n = 12 for mechanics, n = 7 for “bump” measurements). A. Peak active tension. 
B. Relative integral intensity of “bump”. Changes are presented in a % of value measured immediately after stretch (T2 value), dashed 
line shows T2 level. Data are presented as mean ± S.E.M.
A B
160 Lookin et al.
It is well documented in numerous studies that rapid 
increase in contractility occurred immediately after stretch 
is typical in mammalian myocardium. This instant force po-
tentiation is thought to be attributed to the changes in inter-
filament overlap and affinity of regulatory protein troponin 
C to Ca2+ ions (the Frank-Starling mechanism, FSM). The 
FSM is not vanished completely in failing rat myocardium, 
as similar to the previously published findings in failing 
human myocardium (von Lewinski et al. 2009), yet blunted 
substantially accordingly to our recent studies (Lookin et 
al. 2015a, 2015b). Currently, there are numerous evidences 
that adaptation of heart to the changes in load involves both 
fast and slow mechanisms (FSM) which are interrelated 
during global regulation of pump function of a whole heart. 
For instance, slow diastolic filling of ventricular chamber 
involves the stretch of myocardial fibers (FSM) while long-
lasting elevation of intraventricular pressure may trigger the 
epigenetic mechanism of development of physiological (cyclic 
changes in the load) or pathological (constantly elevated load) 
hypertrophy (van Wamel et al. 2000). From this point of view 
it is important to note that some therapies of heart failure – 
inhibition of angiotensin-converting enzyme and angiotensin 
receptor (Abraham et al. 2003) or mineralocorticoid receptors 
(Ennis et al. 2013) – while useful in the treatment of arterial 
hypertension, must nevertheless take into account possible 
side-effects on the slow force response as a regulatory pathway 
of myocardial contraction. 
At last, the present study has been done with impuberal 
rats of both sexes and we did not found sex-related differ-
ences in slow responses either in healthy or in monocro-
taline-treated rats. The myocardium of adult rats might 
still have sex-specific regulation of slow response since sex 
hormones play important role in the preservation of the 
Frank-Starling mechanism under heart failure in female 
myocardium (Ahn et al. 2003; Bal et al. 2013; Lookin et al. 
2015a). Further sex-oriented study of the mechanisms of fast 
and slow regulation of contraction is needed to clarify the 
role of sex hormones in the middle- or long-term control 
of myocardial function. 
In summary, our results support that there is a common 
feature between the mechanism(s) of slow force response 
in normal myocardium and the mechanism(s) of develop-
ment of monocrotaline-induced severe hypertrophy or heart 
failure in rats. This feature is the activation of angiotensin 
type 1 receptors. In normal rat myocardium, this mecha-
nism triggers NHE-1 involving pathway of slow regulation 
of contractility (Cingolani et al. 2011). The depression of 
slow force response in the failing rat myocardium might be 
related to diminished effectiveness of the stretch-induced 
endogenous release of angiotensin on the background of 
elevated level of exogenous angiotensin developed in hy-
pertrophy; the endogenous release may also be blocked in 
this pathological state.
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